The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies.

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...

Cellular manufacturing systems (CMS) represent a pivotal approach to modern industrial production, in which machines and workstations are organised into discrete cells dedicated to the manufacture of ...

What is the current status of cell therapies today? It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the ...